Siemens Healthineers has unveiled an expansion of its Magnetom Flow platform with a new 70-centimetre bore 1.5 Tesla magnetic resonance imaging scanner. The system features DryCool technology, requiring only 0.7 litres of helium compared to conventional 1,500-litre systems, whilst incorporating AI-driven image reconstruction capabilities.
Advanced brain-computer interface technology has enabled individuals with spinal cord injuries to experience complex touch sensations whilst controlling an external bionic hand, marking a significant development in neural prosthetics research.
Phase II trial demonstrates superior outcomes compared to synthetic grafts in both civilian and military settings, with significantly lower amputation rates and infection risks.
Scientists have created the first comprehensive map showing how human DNA is mixed and passed down through generations, offering new understanding of genetic diversity and its relationship to fertility and evolution.
New research published in Nature Reviews Neurology reveals that dementia will become the world’s third leading cause of death by 2040, surpassed only by ischaemic heart disease and stroke, yet continues to be overlooked in major health policy frameworks and resource allocation.
International medical technology company Mindray has introduced new platelet counting technology to European markets, incorporating artificial intelligence and multiple detection methods to enhance accuracy in clinical haematology laboratories. The CAL 8000 Cellular Analysis Line aims to reduce pseudothrombocytopenia and pseudothrombocytosis errors in diagnostic testing.
New research reveals how obesity impairs the function of crucial regulatory T cells in fatty tissue by disrupting their cholesterol metabolism, potentially opening new therapeutic avenues for treating obesity-related metabolic disorders.
Vanderbilt researchers demonstrate effectiveness of automated alerts in prompting suicide risk screening, with interruptive alerts proving significantly more successful than passive notifications.
Novel stimulation protocol helps reduce muscle spasticity and improve walking rehabilitation in patients with incomplete spinal cord injuries, offering hope for enhanced recovery outcomes.
A groundbreaking biomimetic artificial muscle that combines exceptional mechanical properties with tissue regeneration capabilities offers new hope for treating volumetric muscle loss injuries and improving prosthetic applications.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
